Quest Diagnostics (DGX) Income towards Parent Company: 2009-2025
Historic Income towards Parent Company for Quest Diagnostics (DGX) over the last 17 years, with Sep 2025 value amounting to $214.0 million.
- Quest Diagnostics' Income towards Parent Company rose 7.54% to $214.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $844.0 million, marking a year-over-year increase of 16.41%. This contributed to the annual value of $867.0 million for FY2024, which is 2.36% up from last year.
- Latest data reveals that Quest Diagnostics reported Income towards Parent Company of $214.0 million as of Q3 2025, which was down 14.40% from $250.0 million recorded in Q2 2025.
- In the past 5 years, Quest Diagnostics' Income towards Parent Company ranged from a high of $599.0 million in Q2 2021 and a low of $76.0 million during Q4 2022.
- For the 3-year period, Quest Diagnostics' Income towards Parent Company averaged around $194.5 million, with its median value being $196.0 million (2024).
- In the last 5 years, Quest Diagnostics' Income towards Parent Company surged by 830.43% in 2021 and then tumbled by 78.22% in 2022.
- Quest Diagnostics' Income towards Parent Company (Quarterly) stood at $349.0 million in 2021, then crashed by 78.22% to $76.0 million in 2022, then soared by 113.16% to $162.0 million in 2023, then grew by 20.99% to $196.0 million in 2024, then climbed by 7.54% to $214.0 million in 2025.
- Its Income towards Parent Company stands at $214.0 million for Q3 2025, versus $250.0 million for Q2 2025 and $184.0 million for Q1 2025.